Fig. 3From: Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019Associations of resistance to carbapenems with antibacterial usage for the entire study period. BL/BLI: β-lactam/β-lactamase inhibitor; C/BLI: cephalosporin/β-lactamase inhibitor; P/BLI: penicillin/β-Lactamase inhibitor. Consumption of antibiotic was expressed in defined daily doses (DDDs)/1000 patient-daysBack to article page